project id: TCGA-GBM; case submitter id: TCGA-4W-AA9R; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.93; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.48; rna integrity number: 7.7; age at index: 61; days to birth: -22317; ethnicity: not hispanic or latino; gender: male; race: black or african american; vital status: Alive; year of birth: 1951; age at diagnosis: 22317; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 124.0; icd 10 code: C71.9; last known disease status: not reported; morphology: 9440/3; primary diagnosis: Glioblastoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Brain, NOS; synchronous malignancy: No; tissue or organ of origin: Brain, NOS; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 617; days to sample procurement: 0; initial weight: 150.0; portion submitter id: TCGA-4W-AA9R-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 2.0; percent necrosis: 30.0; percent neutrophil infiltration: 0.0; percent normal cells: 5.0; percent stromal cells: 25.0; percent tumor cells: 40.0; percent tumor nuclei: 80.0;